side effects of ipamorelin and cjc 1295 CJC-1295 Effects, Complications, Risk Profile CJC-1295 Peptide: The Basics, Benefits,

Ipamorelin is a synthetic peptide, a growth hormone releasing peptide (GHRP), and a ghrelin mimetic

Biochim Biophys Acta 2013

Whether you run a continuous protocol or cycle on/off periods, nocturnal administration remains optimal during active phases

effects diminish within 2-4 weeks of continuous use Ipamorelin: Maximum Selectivity Ipamorelin was designed specifically for selective GH release: GHS-R1a Selectivity: Activates only GH-releasing pathways at the receptor No Cortisol Effect: Does not stimulate ACTH or cortisol release No Prolactin Effect: Does not affect prolactin levels Minimal Appetite Effect: Unlike other GHRPs, does not significantly increase hunger No Cardiac Activity: Lacks Hexarelin's cardiac receptor effects No Desensitization: Effects maintain with continued use Key Trade-off: Hexarelin offers maximum acute GH release but with hormonal side effects and rapid desensitization

Most users report noticeable changes in sleep quality, recovery, and performance within 24 weeks

Bigger combined pulse Acting on two different triggers produces a bigger combined GH pulse